When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JAZZ - Enrollment underway in mid-stage study of Jazz Pharma's defibrotide
Jazz Pharmaceuticals plc
The first participant has been enrolled in an exploratory Phase 2 clinical trial evaluating Jazz Pharmaceuticals' (NASDAQ:JAZZ) defibrotide for the prevention of neurotoxicity in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving Gilead Sciences' (NASDAQ:GILD) CAR T therapy Yescarta (axicabtagene ciloleucel).
More news on: Jazz Pharmaceuticals plc, Gilead Sciences, Inc., Healthcare stocks news,